Kathryn Gallaway, MD
@ke_gallaway
34 y/o G2P2 presents w/ insatiable thirst for knowledge of unknown etiology | Philosophy @RiceUniversity | MD @UTSWNews | Associate Medical Director @DAVAOnc
ID: 1558842292605259777
https://www.linkedin.com/in/kathryn-gallaway-845136236/ 14-08-2022 15:46:19
958 Tweet
383 Followers
917 Following
Dr. David Miklos Stanford BMT & Cell Therapy kicks of Saturday at #DAVAHeme with intriguing update on secondary malignancy post-CD19 CAR nejm.org/doi/full/10.10… In this patient, the secondary TCL cells were present prior to CAR infusion. Novel mechanism for secondary malignancy post-CAR?